These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25873590)

  • 61. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MECoRank: cancer driver genes discovery simultaneously evaluating the impact of SNVs and differential expression on transcriptional networks.
    Hui Y; Wei PJ; Xia J; Wang YT; Zheng CH
    BMC Med Genomics; 2019 Dec; 12(Suppl 7):140. PubMed ID: 31888623
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synonymous mutations frequently act as driver mutations in human cancers.
    Supek F; Miñana B; Valcárcel J; Gabaldón T; Lehner B
    Cell; 2014 Mar; 156(6):1324-1335. PubMed ID: 24630730
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
    Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
    EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.
    Jia P; Zhao Z
    PLoS Comput Biol; 2014 Feb; 10(2):e1003460. PubMed ID: 24516372
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New discoveries of old SON: a link between RNA splicing and cancer.
    Hickey CJ; Kim JH; Ahn EY
    J Cell Biochem; 2014 Feb; 115(2):224-31. PubMed ID: 24030980
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exon junction sequences as cryptic splice sites: implications for intron origin.
    Sadusky T; Newman AJ; Dibb NJ
    Curr Biol; 2004 Mar; 14(6):505-9. PubMed ID: 15043816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Network-based Identification of novel cancer genes.
    Ostlund G; Lindskog M; Sonnhammer EL
    Mol Cell Proteomics; 2010 Apr; 9(4):648-55. PubMed ID: 19959820
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.
    Gonzalez-Perez A
    Genome Med; 2016 Jan; 8(1):6. PubMed ID: 26792175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks.
    Kalender Atak Z; Imrichova H; Svetlichnyy D; Hulselmans G; Christiaens V; Reumers J; Ceulemans H; Aerts S
    Genome Med; 2017 Aug; 9(1):80. PubMed ID: 28854983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detecting positive and purifying selection at synonymous sites in yeast and worm.
    Zhou T; Gu W; Wilke CO
    Mol Biol Evol; 2010 Aug; 27(8):1912-22. PubMed ID: 20231333
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanistic-enriched models: integrating transcription factor networks and metabolic deregulation in cancer.
    Hernández-Lemus E; Siqueiros-García JM
    Theor Biol Med Model; 2015 Sep; 12():16. PubMed ID: 26353769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mathematical modeling identifies potential gene structure determinants of co-transcriptional control of alternative pre-mRNA splicing.
    Davis-Turak J; Johnson TL; Hoffmann A
    Nucleic Acids Res; 2018 Nov; 46(20):10598-10607. PubMed ID: 30272246
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reconstruction of a generic metabolic network model of cancer cells.
    Hadi M; Marashi SA
    Mol Biosyst; 2014 Nov; 10(11):3014-21. PubMed ID: 25196995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
    Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
    J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Genetic Screen for Pre-mRNA Splicing Mutants of
    Kanno T; Lin WD; Fu JL; Chang CL; Matzke AJM; Matzke M
    Genetics; 2017 Dec; 207(4):1347-1359. PubMed ID: 28971960
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer.
    Bashashati A; Haffari G; Ding J; Ha G; Lui K; Rosner J; Huntsman DG; Caldas C; Aparicio SA; Shah SP
    Genome Biol; 2012 Dec; 13(12):R124. PubMed ID: 23383675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hotspot exons are common targets of splicing perturbations.
    Glidden DT; Buerer JL; Saueressig CF; Fairbrother WG
    Nat Commun; 2021 May; 12(1):2756. PubMed ID: 33980843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Global transcription network incorporating distal regulator binding reveals selective cooperation of cancer drivers and risk genes.
    Kim K; Yang W; Lee KS; Bang H; Jang K; Kim SC; Yang JO; Park S; Park K; Choi JK
    Nucleic Acids Res; 2015 Jul; 43(12):5716-29. PubMed ID: 26001967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.